Because of Jeff's personal experience with this medical technology, he thinks it can alter the world: "it's an amazing brand-new pattern in medicine driven by innovation that found cancer. And provided me a fighting opportunity to beat it incredibly early before it became a possibly deadly problem." Jeff does not simply recommend buying this business to take advantage of this trend.
: "But there's more to this technology than just saving my life. By subscribing to The Near Future Report today, you can discover how this technology works, what it does, and why Jeff believes it will change the world of medicine.
"There's Biolife Sciences, which rose as high as 41,800% in less than a year, A small, $1,000 stake might have revived as much as $418,000." The sales page is filled with comparable gains. Jeff Brown utilizes Mirati Therapeutics as an example, which increased 8,481% in under two years. Other gains included on The Near Future Report's sales page include: Jeff Brown is cautious to describe that previous incomes do not guarantee future results.
He does not suggest allocating a substantial part of your portfolio to these stocks. Nevertheless, Jeff also claims he has "visited providers and done his own research study on future earnings" to confirm his recommendations. Based upon that analysis, Jeff is positive that some of his biotech stock picks will rise significantly in the future.
2 Trillion Industry that Could Conserve Millions of Lives? Jeff, like numerous investors, thinks biotech will be one of the hottest tech patterns over the coming years. Biotech is no secret.
Jeff discusses precision medicine as one example: "the biotech market is expected to grow 86% over the next few years. That is remarkable. But listen to this, The precision medication market is expected to grow 152% throughout that very same time" Precision medication is an emerging location of biotech that uses accurate biological data to calculate disease threat.
